Cargando…
Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial
OBJECTIVES: The aim of this paper was to analyse the impact of obesity, in addition to known predictors, on disease outcome in early rheumatoid arthritis (RA). METHODS: Body mass index (BMI) was available in 260 patients from the Swedish pharmacotherapy trial (SWEFOT). Differences in disease activit...
Autores principales: | Levitsky, Adrian, Brismar, Kerstin, Hafström, Ingiäld, Hambardzumyan, Karen, Lourdudoss, Cecilia, van Vollenhoven, Ronald F, Saevarsdottir, Saedis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RMD Open
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574420/ https://www.ncbi.nlm.nih.gov/pubmed/28879052 http://dx.doi.org/10.1136/rmdopen-2017-000458 |
Ejemplares similares
-
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial
por: Hambardzumyan, Karen, et al.
Publicado: (2016) -
A Multi‐Biomarker Disease Activity Score and the Choice of Second‐Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure
por: Hambardzumyan, Karen, et al.
Publicado: (2017) -
Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi‐Biomarker Disease Activity Score as an Inclusion Criterion
por: van Vollenhoven, Ronald F., et al.
Publicado: (2015) -
Does autoimmune thyroid disease affects rheumatoid arthritis disease activity or response to methotrexate?
por: Waldenlind, Kristin, et al.
Publicado: (2020) -
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study
por: Tidblad, Liselotte, et al.
Publicado: (2022)